Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension.
Journal Articles
Part of the Medicine and Health Sciences Commons
Skip to main content